CPT® Code 81209

The CPT® Code 81209 pertains to the molecular genetic testing aimed at identifying a specific mutation in the BLM (Bloom syndrome, RecQ helicase-like) gene, particularly the 2281del6ins7 variant. Bloom syndrome is an autosomal recessive disorder, meaning that it manifests when an individual inherits mutations in the BLM gene from both parents. Those who inherit the mutation from only one parent are considered carriers and typically do not exhibit symptoms of the syndrome. This condition is most prevalent among individuals of Ashkenazi Jewish descent, particularly those from Central and Eastern Europe, where the 2281del6ins7 or blmAsh variant is commonly found. The BLM gene is crucial for producing the RecQ helicase protein, an enzyme that plays a vital role in DNA replication by unwinding the double helix structure, allowing for the accurate copying of genetic material into sister chromatids. When mutations occur in the BLM gene, they disrupt genome stability, leading to an increased rate of sister chromatid exchange, which can result in gaps or breaks in the DNA sequence. This impairment can hinder normal cellular functions, promote cell death, and slow down growth. The BLM enzyme is essential for maintaining DNA stability and can also help restart the DNA replication process when it encounters obstacles. Genetic testing for the BLM mutation is critical for identifying carriers and diagnosing individuals with Bloom syndrome. The clinical features associated with the BLM mutation include short stature, distinctive facial rashes, high-pitched voice, and various skin changes, among others. Additionally, individuals with this mutation may experience immune system disorders, increased cancer risk, reproductive issues, and cognitive challenges.